Updated: Addendum to ACMD's NBOMe advice added.
This paper reviews the evidence of misuse and harm in relation to the NBOMe compounds, which has been considered by ACMD at meetings of the Novel Psychoactive Substances Committee in April 2013 and by the full Council in May and October 2013.